EUVIMEDEUVIMED entdecken
Open Access

CRP–Albumin–Lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Recurrent Esophageal Cancer After Curative Treatment

Maki Takagi, Toru Aoyama, Itaru Hashimoto, Taiichi Kawabe, Yukio Maezawa, Sho Sato, Kanechika DEN, Takashi Kosaka, Tsutomu Sato, Yosuke Atsumi, Miki Kayashima, Kohei Sekiguchi und 6 weitere

In Vivo · 2026-11 · 40 (6) · 3821-3829

DOI: 10.21873/invivo.14518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, online erschienen am 29.10.2026. Verfasst von Maki Takagi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Yokohama City University, Yokohama, Japan; takagi.mak.jz@yokohama-cu.ac.jp. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoplasm Recurrence, Local, C-Reactive Protein, Biomarkers, Tumor. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: The C-reactive protein-albumin-lymphocyte (CALLY) index is a promising biomarker. We investigated the prognostic significance of the CALLY index in patients with recurrent esophageal cancer (EC). PATIENTS AND METHODS: Consecutive patients who developed recurrent EC after curative esophagectomy and received treatment for recurrence at Yokohama City University from 2005 to 2022 were selected based on medical records. The CALLY index was calculated as follows: serum albumin level (g/dl) × peripheral lymphocyte count (/μl)/[C-reactive protein level (mg/dl) × 104]. The primary endpoint was overall survival after recurrence. The secondary endpoint was the association between the CALLY index and the clinical course after recurrence, including the administration of first-, second-, and third- line treatments. RESULTS: One hundred patients were included in this retrospective study. The cut-off value for the CALLY index was set at 5. The 5-year overall survival rates were 11.2% and 46.9% for the low and high CALLY index groups, respectively (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsNeoplasm Recurrence, LocalC-Reactive ProteinBiomarkers, TumorLymphocytesSerum AlbuminHumansPrognosisFemaleMaleAgedMiddle AgedLymphocyte CountRetrospective Studies

Stichwörter der Autor:innen

CALLY indexesophageal canceroverall survivalprognosisrecurrence

Substanzen

C-Reactive ProteinBiomarkers, TumorSerum Albumin

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Yokohama City University, Yokohama, Japan; takagi.mak.jz@yokohama-cu.ac.jp.
  • Department of Surgery, Yokohama City University, Yokohama, Japan.
  • Department of Gastrointestinal Surgery, Yokohama City University, Yokohama, Japan.
  • Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

Zitieren

APA

Takagi, M., Aoyama, T., Hashimoto, I., Kawabe, T., Maezawa, Y., Sato, S., DEN, K., Kosaka, T., Sato, T., Atsumi, Y., Kayashima, M., Sekiguchi, K., Tamagawa, A., Kazama, K., Sugano, N., Cho, H., Yukawa, N., & Yoshikawa, T. (2026). CRP–Albumin–Lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Recurrent Esophageal Cancer After Curative Treatment. In Vivo, 40(6), 3821-3829. https://doi.org/10.21873/invivo.14518

Vancouver

Takagi M, Aoyama T, Hashimoto I, Kawabe T, Maezawa Y, Sato S, et al. CRP–Albumin–Lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Recurrent Esophageal Cancer After Curative Treatment. In Vivo. 2026;40(6):3821-3829. doi:10.21873/invivo.14518

BibTeX
@article{Takagi2026,
  author = {Takagi, Maki and Aoyama, Toru and Hashimoto, Itaru and Kawabe, Taiichi and Maezawa, Yukio and Sato, Sho and DEN, Kanechika and Kosaka, Takashi and Sato, Tsutomu and Atsumi, Yosuke and Kayashima, Miki and Sekiguchi, Kohei and Tamagawa, Ayako and Kazama, Keisuke and Sugano, Nobuhiro and Cho, Haruhiko and Yukawa, Norio and Yoshikawa, Takaki},
  title = {CRP–Albumin–Lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Recurrent Esophageal Cancer After Curative Treatment},
  journal = {In Vivo},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {3821--3829},
  doi = {10.21873/invivo.14518}
}
Kostenlos starten →